DOT GmbhNovember 16, 2023

FDA 483 - DOT Gmbh - November 16, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore DOT Gmbh

Record Details

An FDA inspection of DOT GmbH, a manufacturer in Rostock, Germany, revealed significant deficiencies in the firm's quality system. The inspection found that procedures for receiving, reviewing, and evaluating complaints and nonconformances were not adequately established. Specifically, the firm failed to provide sufficient documentation and details within nonconformance reports regarding effectiveness monitoring and root cause investigations.

Company: DOT Gmbh
Inspection Date: November 16, 2023
Product Type: Device
Office: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
Person: John A. Sciacchitano (investigator)

Open in Dashboard

ID · c3039592-965b-4f77-a5a7-fdad16c1cc23